Craft

Accuray

Stock Price

$1.9

2024-10-29

Market Capitalization

$186.5 M

2024-10-29

Revenue

$446.6 M

FY, 2024

Accuray Summary

Company Summary

Overview
Accuray is a radiation therapy company that manufactures, sells, and supports radiation treatment solutions. It offers radiation therapy systems, treatment planning software, imaging solutions, automated tools, etc. The company develops the CyberKnife platform used by neurosurgeons specializing in radiosurgery to treat patients with tumors in the brain and spine and neurologic and endocrine disorders: and the TomoTherapy platform that allows radiation treatment planning, delivery, data management, and other services.
Type
Public
Status
Active
Founded
1990
HQ
Madison, WI, US | view all locations
Website
https://www.accuray.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Joshua Levine

    Joshua Levine, Chief Executive Officer

  • Suzanne Winter
  • Mika Nishimura

    Mika Nishimura, Independent Director

    • Scott Chapman

      Scott Chapman, Senior Vice President, Global Service

    Operating MetricsView all

    Patents Issued

    456
    4.8%

    FY, 2019

    Patent Applications

    110
    26.4%

    FY, 2019

    Backlog

    $495.6M
    3.6%

    FY, 2019

    LocationsView all

    7 locations detected

    • Madison, WI HQ

      United States

      1240 Deming Way

    • Santa Clara, CA

      United States

      3979 Freedom Cir #700

    • Sunnyvale, CA

      United States

      1310 Orleans Dr

    • Chengdu, Sichuan Sheng

      China

      No. 8, Kexin Road, Hi-Tech Zone (West Area)

    • Kowloon, Kowloon

      Hong Kong

      Suite 401, 4/F, Empire Centre, 68 Mody Road, T.S.T

    • Tokyo, Tōkyō-to

      Japan

      Shin Otemachi Building 7F 2-2-1 Otemachi, Chiyoda-ku

    and 1 others

    Accuray Financials

    Summary Financials

    Revenue (Q3, 2025)
    $113.2M
    Gross profit (Q3, 2025)
    $31.6M
    Net income (Q3, 2025)
    ($1.3M)
    Cash (Q3, 2025)
    $77.8M
    EBIT (Q3, 2025)
    $1.0M
    Enterprise value
    $282.5M

    Footer menu